IMMERSE: Innovative Malaria M&E, Research and Surveillance towards Elimination: S

沉浸：创新型疟疾 M

• 批准号: 9108581
• 负责人: Sylvia Meek
• 金额: $ 27.88万
• 依托单位: MALARIA CONSORTIUM
• 依托单位国家: 美国
• 财政年份: 2013
• 资助国家: 美国
• 起止时间: 2013-09-01 至 2018-08-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9108581
• 关键词: IMMERSE; Innovative; Malaria; M&E; Research

DESCRIPTION (provided by applicant): The aim of this program is to improve malaria program implementation in the Greater Mekong Sub-region (GMS) (with a particular focus on Myanmar, Cambodia and Thailand), and build a robust and reliable evidence platform capable of developing and evaluating operational research, surveillance, and monitoring & evaluation (M&E) activities to inform policies and practices in conjunction with national malaria control programs and other partners. The specific aims are as follows: Develop and refine M&E and surveillance tools in order to assess the impact of existing interventions, monitor short-term malaria burden and transmission trends and inform programs on when to move from control to elimination strategies. To monitor artemisinin and artemisinin combination therapy ACT resistance using innovative approaches to conduct a series of OR activities to assess country-specific feasibility of malaria active case detection interventions, evaluation of innovative delivery mechanisms to target hard to reach populations and point of care diagnostics. Promote use of knowledge by local and national policy makers and program planners ensuring strategic information is disseminated and shared among GMS and sub-Saharan Africa (SSA), and best practices harmonized in the region. The principal approach will be to strengthen national programs capacity to move from malaria control to elimination and to support artemisinin resistance containment through the implementation and use of robust and innovative M&E, surveillance, and operational research. Malaria Consortium works closely with national malaria programs and partners through provision of technical assistance and implementation support. We shall focus on operationalizing the useful tools and promoting their uptake. In addition to its own team MC will engage key technical assistance from London School of Hygiene & Tropical Medicine and Institute Pasteur in Cambodia as well as some independent consultants, and if savings are made, MC will also engage Health Poverty Action for work in the special regions of eastern Burma. We shall work in strong collaboration with CDC and with WHO, and shall provide technical support also when needed to other PMI supported programs. By the end of the program we expect that a much higher standard of surveillance will be fully operational in partner countries, and key responses to malaria problem areas will be designed and implemented.

描述（由申请人提供）： 该计划的目的是改善大湄公河次区域（GMS）的疟疾计划实施情况（特别关注缅甸，柬埔寨和泰国），并建立一个强大而可靠的证据平台，能够开发和评估业务研究，监测，监测和评估（M&E）活动，与国家疟疾控制计划和其他合作伙伴一起为政策和实践提供信息。具体目标如下：开发和完善监测和评价及监测工具，以评估现有干预措施的影响，监测短期疟疾负担和传播趋势，并就何时从控制战略转向消除战略向各方案提供信息。监测青蒿素和青蒿素综合疗法的耐药性，采用创新办法开展一系列OR活动，以评估针对具体国家的疟疾主动病例检测干预措施的可行性，评价针对难以接触到的人群的创新交付机制和护理点诊断。促进地方和国家决策者和方案规划者利用知识，确保战略信息在GMS和撒哈拉以南非洲之间传播和共享，并在该地区统一最佳做法。主要方法将是加强国家方案的能力，从疟疾控制转向消除，并通过实施和使用强有力的创新性监测和评价、监测和业务研究，支持青蒿素耐药性遏制。疟疾联合会通过提供技术援助和实施支持，与国家疟疾方案和伙伴密切合作。我们将侧重于使这些有用的工具投入运作并促进其应用。除了自己的团队外，MC还将从伦敦卫生与热带医学学院和柬埔寨巴斯德研究所以及一些独立顾问那里获得关键技术援助，如果节省了资金，MC还将在缅甸东部的特殊地区开展健康贫困行动。我们将与疾病预防控制中心和世卫组织密切合作，并在需要时向其他PMI支持的项目提供技术支持。我们预计，到该计划结束时，伙伴国家将全面实施更高标准的监测，并将设计和实施针对疟疾问题地区的关键对策。